Summary: Health policy makers and research leaders discussed the impact of new trends in digital technologies and advanced data analysis on precision medicine and implications for regulatory decision-making. While digital technologies are rapidly applied in innovative ways to develop new diagnostics and therapies, the ultimate approval and adoption of these emerging methods presents several scientific and regulatory challenges.
Click here for an agenda and list of participants.
Click here to view a background article by Joan Adamo, et al. titled “Translation of Digital Health Technologies to Advance Precision Medicine: Informing Regulatory Science.”
Details: The conference was held Thursday, September 27, 2018 at PhRMA Foundation headquarters in Washington, D.C.
For more information about the conference, please call (202) 572-7756 or send an email to email@example.com.